Linkesch W - Search Results

1

[Defects in the prostaglandin system. IX. Lipoxygenase defect of thrombocytes in a patient with polycythemia vera].

Sinzinger H, Gisslinger H, Linkesch W, Peskar BA. Sinzinger H, et al. Among authors: linkesch w. Wien Klin Wochenschr. 1990 Feb 2;102(3):74-6. Wien Klin Wochenschr. 1990. PMID: 2107637 German.

2

[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].

Sinzinger H, Gisslinger H, Linkesch W, Ludwig H, Flener R, Peskar BA. Sinzinger H, et al. Among authors: linkesch w. Wien Klin Wochenschr. 1988 Nov 4;100(21):715-8. Wien Klin Wochenschr. 1988. PMID: 3149432 German.

3

Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alpha.

Sinzinger H, Linkesch W, Ludwig H, Gisslinger H, O'Grady J, Peskar BA. Sinzinger H, et al. Among authors: linkesch w. Prostaglandins. 1990 Oct;40(4):351-60. doi: 10.1016/0090-6980(90)90100-a. Prostaglandins. 1990. PMID: 2126385

4

[The cholesterol risk factor--initial results of a screening study in industries].

Flores J, Widhalm K, Kuzmits R, Linkesch W, Sabeti M, Sinzinger H. Flores J, et al. Among authors: linkesch w. Wien Klin Wochenschr. 1989 Jun 9;101(12):412-7. Wien Klin Wochenschr. 1989. PMID: 2750167 German.

5

[Cholesterol screening in a bank for the detection of a risk population].

Flores J, Richter H, Weiss K, Linkesch W, Widhalm K, Kuzmits R, Sinzinger H. Flores J, et al. Among authors: linkesch w. Wien Klin Wochenschr. 1989 Jun 9;101(12):419-23. Wien Klin Wochenschr. 1989. PMID: 2750169 German.

6

[Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].

Linkesch W, Gisslinger H, Ludwig H, Flener R, Sinzinger H. Linkesch W, et al. Acta Med Austriaca. 1985;12(5):123-7. Acta Med Austriaca. 1985. PMID: 3914173 Clinical Trial. German.

7

Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.

Ludwig H, Linkesch W, Gisslinger H, Fritz E, Sinzinger H, Radaszkiewicz T, Chott A, Flener R, Micksche M. Ludwig H, et al. Among authors: linkesch w. Cancer Immunol Immunother. 1987;25(3):266-73. doi: 10.1007/BF00199157. Cancer Immunol Immunother. 1987. PMID: 3677127 Free PMC article.

8

Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.

Ludwig H, Cortelezzi A, Van Camp BG, Polli E, Scheithauer W, Kuzmits R, Linkesch W, Gisslinger H, Sinzinger H, Fritz E, et al. Ludwig H, et al. Among authors: linkesch w. Oncology. 1985;42 Suppl 1:19-25. doi: 10.1159/000226080. Oncology. 1985. PMID: 4080297 Clinical Trial.

9

Interferon-alpha-induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosis.

Chott A, Gisslinger H, Thiele J, Fritz E, Linkesch W, Radaszkiewicz T, Ludwig H. Chott A, et al. Among authors: linkesch w. Br J Haematol. 1990 Jan;74(1):10-6. doi: 10.1111/j.1365-2141.1990.tb02531.x. Br J Haematol. 1990. PMID: 2310690

10

Long-term interferon therapy for thrombocytosis in myeloproliferative diseases.

Gisslinger H, Ludwig H, Linkesch W, Chott A, Fritz E, Radaszkiewicz T. Gisslinger H, et al. Among authors: linkesch w. Lancet. 1989 Mar 25;1(8639):634-7. doi: 10.1016/s0140-6736(89)92142-9. Lancet. 1989. PMID: 2564458 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters